Cargando…
Assessment of Lipid Peroxidation in Alzheimer’s Disease Differential Diagnosis and Prognosis
Alzheimer’s disease (AD) and other dementias are becoming increasingly common in the older population, and the number of people affected is expected to increase in a few years. Nowadays, biomarkers used in early AD diagnosis are expensive and invasive. Therefore, this research field is growing. In f...
Autores principales: | Ferré-González, Laura, Peña-Bautista, Carmen, Baquero, Miguel, Cháfer-Pericás, Consuelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944831/ https://www.ncbi.nlm.nih.gov/pubmed/35326200 http://dx.doi.org/10.3390/antiox11030551 |
Ejemplares similares
-
Assessment of Screening Approach in Early and Differential Alzheimer’s Disease Diagnosis
por: Ferré-González, Laura, et al.
Publicado: (2021) -
Clinical Utility of Plasma Lipid Peroxidation Biomarkers in Alzheimer’s Disease Differential Diagnosis
por: Peña-Bautista, Carmen, et al.
Publicado: (2020) -
Lipid Peroxidation Assessment in Preclinical Alzheimer Disease Diagnosis
por: Peña-Bautista, Carmen, et al.
Publicado: (2021) -
Lipids as Early and Minimally Invasive Biomarkers for Alzheimer’s Disease
por: Casas-Fernández, Esther, et al.
Publicado: (2022) -
Assessment of Plasma and Cerebrospinal Fluid Biomarkers in Different Stages of Alzheimer’s Disease and Frontotemporal Dementia
por: Álvarez-Sánchez, Lourdes, et al.
Publicado: (2023)